(Q35895019)
Statements
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study (English)
S C Schold
J G Kuhn
S M Chang
M E Bosik
H I Robins
A M Spence
D Fulton
K L Fink
Identifiers
1 reference